Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q3 FY24 results · Oct–Dec 2023
Medplus Health Services reported revenue from operations of ₹1,441.47 crore (up 21.1% from Q3 FY23) and net profit of ₹13.71 crore (up 2.4% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,441.47 | 1,190.31 | +21.1% | 1,408.59 | +2.3% |
| Other income | 9.79 | 11.36 | −13.8% | 10.37 | −5.5% |
| Total income | 1,451.26 | 1,201.67 | +20.8% | 1,418.95 | +2.3% |
| Profit before tax | 19.96 | 16.21 | +23.1% | 16.44 | +21.4% |
| Net profit for the period | 13.71 | 13.38 | +2.4% | 14.54 | −5.8% |
| Attributable to shareholders of the company | 13.73 | 13.41 | +2.4% | 14.56 | −5.8% |
| EPS, basic (₹) | 1.15 | 1.12 | +2.7% | 1.22 | −5.7% |
| Net margin (%) | 1.0 | 1.1 | 1.0 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 148.10 | 57.24 | +158.7% | 98.67 | +50.1% |
| Other income | 1.82 | 4.07 | −55.2% | 1.76 | +3.3% |
| Total income | 149.92 | 61.31 | +144.5% | 100.44 | +49.3% |
| Profit before tax | 4.24 | 1.78 | +138.2% | (0.04) | Turned profit |
| Net profit for the period | 3.19 | 0.62 | +414.2% | (0.04) | Turned profit |
| EPS, basic (₹) | 0.27 | 0.15 | +80.0% | 0.05 | +440.0% |
| Net margin (%) | 2.2 | 1.1 | -0.0 |
Consolidated
- Filed with BSE
- 03 Feb 2024, 12:47 IST
- Board meeting
- 02 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Feb 2024, 12:47 IST
- Board meeting
- 02 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE